Immunohistochemistry (IHC) Market by Trend, Share, Size and
Streamline Inspection and Forecast to 2030

Immunohistochemistry (IHC) Market research
report by Delvens focuses on primary sections such as – market segments, market
outlook, competitive landscape, and company profiles. The segments provide
details in terms of various perspectives such as end-use industry, product or
service type, and any other relevant segmentation as per the market’s current
scenario which includes various aspects to perform further marketing activity,
the global immunohistochemistry market is projected to reach USD 3.3 billion by
2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period
to 2030.

Get Free Sample
Report: https://www.delvens.com/get-free-sample/immunohistochemistry-market

A laboratory method that uses antibodies to check for
certain antigens (markers) in a sample of tissue. The antibodies are usually
linked to an enzyme or a fluorescent dye. IHC has become a crucial technique
and is widely applied in the diagnosis of several chronic diseases such as
cancer, infectious diseases, and cardiovascular diseases (CVDs).

The rising geriatric population and subsequent growth in
prevalence of chronic and infectious diseases, technological advancements in
IHC, and availability of reimbursements for IHC tests are some of the factors that
have supported long-term expansion for Immunohistochemistry (IHC) Market.

Regional Analysis

North America was the largest regional market for
immunohistochemistry market in 2020. APAC is expected to register the fastest
growth rate during the forecast period owing to several factors, including
increasing disposable income, rising healthcare spending, growing demand for
quality medical care, and increasing investments by pharmaceutical and
biopharmaceutical companies.

Recent Developments

Roche received FDA approval for VENTANA MMR RxDx companion
diagnostic test based on immunohistochemistry for solid tumors that are
deficient in the MMR pathway. The test identifies patients eligible for GSK’s
anti-PD1 immunotherapy, JEMPERLI.

Agilent received a CE-IVD mark in Europe for its PD-L1 IHC
22C3 pharmDx assay for the identification of oesophageal cancer patients for
treatment with KEYTRUDA.

Key Players of Immunohistochemistry (IHC) Market:

·       
F. Hoffman-La Roche AG

·       
Danaher Corporation

·       
Agilent Technologies, Inc.

·       
Merck KGaA

·       
Bio-Rad Laboratories, Inc.

·       
Bio-Techne Corporation

·       
Abcam plc

·       
Becton, Dickinson and Company

·       
PerkinElmer, Inc.

·       
Takara Bio, Inc.

·       
Thermo Fisher Scientific, Inc.

·       
PHC Holdings Corporation

·       
Cell Signaling Technology, Inc.

·       
Bio SB, Inc.

·       
Miltenyi Biotec

·       
CANDOR Bioscience GmbH

·       
Sakura Finetek Japan Co., Ltd. and More

Immunohistochemistry
(IHC) Market is segmented into product, application, end user and region.

On the basis of
Product

·       
Antibodies

·       
Reagents

·       
Equipment

·       
kits

On the basis of
Application

·       
diagnostic applications

·       
research applications

·       
forensic applications

On the basis of
End-User

·       
Hospitals & Diagnostic Laboratories

·       
Academic & research Institutes

·       
Other end users

On the basis of Region

·       
Asia Pacific

·       
North America

·       
Europe

·       
South America

·       
Middle East & Africa

Access Full Report: https://www.delvens.com/report/immunohistochemistry-market

In addition to the
market data for Immunohistochemistry (IHC) Market, Delvens offers
client-centric report and customized according to the company’s specific demand
and requirement.

More Related Reports:

Coronary Stent Market

Automotive Diagnostic Scan Tools Market

About Us:

Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.

Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical,
Consumer Goods & Services, Food & Beverages. Our company provides an
exhaustive and comprehensive understanding of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301,
IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com